Article in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors.
Agustin Resendiz-SharpeDepartment of Imaging and Pathology, Faculty of Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0002-2000-1030
Carmen KandelbauerDepartment of Hygiene, Microbiology and Virology, Institute of Hygiene and Medical Microbiology, Medical University Innsbruck, Innsbruck, Austria.
Maria Isabel Navarro MendozaDepartment of Plant Science and Microbiology, Miguel Hernández University, Elche, Spain.ORCID 0000-0002-3560-6155
Giel LemmensFaculty of Engineering Technology, KU Leuven, Leuven, Belgium.
Jakob SchelerDepartment of Hygiene, Microbiology and Virology, Institute of Hygiene and Medical Microbiology, Medical University Innsbruck, Innsbruck, Austria.
Ingo BauerInstitute of Molecular Biology, Biocenter, Medical University Innsbruck, Innsbruck, Austria.ORCID 0000-0002-3316-7769
Eliane VanhoffelenDepartment of Imaging and Pathology, Faculty of Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0003-1938-254X
Laura SeldeslachtsDepartment of Imaging and Pathology, Faculty of Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0002-9562-2923
Lander de HerdtDepartment of Imaging and Pathology, Faculty of Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0001-9229-8841
Lauren MichielsDepartment of Imaging and Pathology, Faculty of Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0002-4999-8532
Flore BelmansDepartment of Imaging and Pathology, Faculty of Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0002-8944-6898
Francisco E NicolásDepartamento de Genética y Microbiología, Facultad de Biología, Universidad de Murcia, Murcia, Spain.ORCID 0000-0003-3762-5971
Cornelia Lass-FlörlDepartment of Hygiene, Microbiology and Virology, Institute of Hygiene and Medical Microbiology, Medical University Innsbruck, Innsbruck, Austria.ORCID 0000-0002-2946-7785
Katrien LagrouDepartment of Microbiology, Immunology and Transplantation, Laboratory of Clinical Microbiology, KU Leuven, Leuven, Belgium.ORCID 0000-0001-8668-1350
Victoriano GarreDepartamento de Genética y Microbiología, Facultad de Biología, Universidad de Murcia, Murcia, Spain.ORCID 0000-0001-7605-1726
Ulrike BinderDepartment of Hygiene, Microbiology and Virology, Institute of Hygiene and Medical Microbiology, Medical University Innsbruck, Innsbruck, Austria.ORCID 0000-0002-2160-2903
Greetje Vande VeldeDepartment of Imaging and Pathology, Faculty of Medicine, KU Leuven, Leuven, Belgium.ORCID 0000-0002-5633-3993
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Mucormycosis, a disease encompassing life-threatening fungal infections by members of the Mucorales group, is characterized by significant heterogeneity, poor clinical outcomes, and globally rising incidences. Although showing clear outbreak potential, the disease remains poorly understood. Mucorales infections are characterized by rapid progression and extensive tissue destruction, often requiring disfiguring surgical interventions. Moreover, intrinsic resistance and high drug tolerance limit antifungal effectiveness, contributing to the disease's high mortality. To overcome the challenges associated with these infections, a deeper understanding of mucormycosis is urgently needed. Valuable translational insights traditionally derive from
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Unveiling Mucorales infections: A cutting-edge longitudinal imaging approach for real-time infection and host-response monitoring in · full record | Socratic